Focus on Patients
-
Closing The Gender Gap In Clinical Trials With Digital Devices
8/15/2025
For decades, women have been underrepresented in clinical trials — a gap that’s not just unfortunate but dangerous. Digital devices might be the difference maker, says research physician Anita Phung, MRGCP, MRCP, MBBS, BSc (Hons).
-
Why Are We So Afraid To Pay Research Participants?
8/1/2025
Clinical researchers have long toiled over paying trial participants. Now, 1Day Sooner patient advocates explain why ethics and actual regulator sentiment should move industry to change its approach to participant payment.
-
Age Restrictions In Clinical Trials Unjustly Harm Adults With Childhood Cancer
7/28/2025
How old is too old for a pediatric cancer trial? Mom-turned-patient advocate Rosemary Sherrod argues that too-stringent age criteria wrongly exclude pediatric cancer patients as they approach adulthood.
-
More Personalized, Precision Medicine Needed In Psychiatry Clinical Trials
7/16/2025
Arrivo Bioventures' Joel Raskin, MD, and Greg Rigdon, Ph.D., discuss the importance of personalized and precision medicine in psychiatry clinical trials.
-
From Protocol To People: Teva's Patient-First Clinical Trials Approach
7/14/2025
Teva Pharmaceuticals' Head of Global Early Clinical Development Eran Harary, MD, shares how the company approaches drug development by getting patient input early and often.
-
2 Challenges In Designing A Clinical Trial Exploring Personalized Elimination Diets
7/3/2025
Vibrant Wellness clinical coordinator Suzanne Barker, MS, RDN, LDN, CGP, discusses how they faced and resolved two key issues when conducting a food sensitivity clinical trial.
-
Gilead Art Campaign Captures The PBC Patient Experience, Inspires Patient-Centric Trials
6/27/2025
Gilead’s Carrie Frenette discusses the company's art campaign centered on primary biliary cholangitis to bring awareness to the condition and create more patient-centric trials for patients.
-
Population-Aware Medicine: Mitigating Racial Disparities In Efficacy And Accuracy
6/26/2025
Medicine is not one-size-fits-all. Here, strategic advisor Bill Hanlon implores pharma to develop therapeutics and diagnostics anchored by racial and ethnic diversity.
-
Single Peptides & Pig Testing: How Longhorn's Developing Its Universal Flu Shot
6/19/2025
CEO Jeff Fischer discusses Longhorn's long-acting universal flu vaccine, from its suitability for testing in pigs to overcoming vaccine hesitancy.
-
BioMarin Generates Patient Experience Data With Early And Often Engagement
6/18/2025
BioMarin Pharmaceutical's Ebony Dashiell-Aje, Ph.D., discusses how early and often patient engagement facilitates rich patient experience data generation.